Comment | |
Short-term | |
Hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) |
|
Large for gestational age newborn or macrosomia |
|
Polyhydramnios |
|
Operative delivery (cesarean birth, forceps- or vacuum-assisted vaginal birth) | |
Fetal/neonatal cardiomyopathy |
|
Neonatal respiratory problems |
|
Neonatal metabolic problems (hypoglycemia, hyperbilirubinemia, hypocalcemia, hypomagnesemia, polycythemia and hyperviscosity syndrome) |
|
Longterm | |
Maternal | |
|
|
|
|
Offspring | |
|
The risks of these outcomes increase as maternal fasting plasma glucose levels increase above 75 mg/dL (4.2 mmol/L) and as the one- and two-hour oral glucose tolerance test values increase from the lowest septile to the highest. This is a continuous effect; there is no clear threshold that defines patients at increased risk of adverse obstetric outcome.
The small increase in congenital anomalies observed in some population-based studies of GDM is likely related to undiagnosed preexisting type 2 diabetes mellitus or maternal obesity.